Capsule Endoscopy Market Information By Product (Capsule Endoscopes, {Small Bowel, Esophageal, and Colon} and Systems), By Application (OGIB (Obscure GI Tract Bleeding), Crohn’s Disease, Small Intestine Tumor, And Others), By End User (Hospitals, Ambulatory Surgery Centers And Other), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030

Global Capsule Endoscopy Market Research (MRFR Insights)

The  capsule endoscopy market size is projected to reach USD 1.29 billion by 2030, at a CAGR of 8.4% from 2022 to 2030. Capsule endoscopy market research trends include the growing prevalence of cancer, increasing  geriatric population base, growing demand for minimally invasive diagnostic procedures, and establishment of technologically advanced capsules are the major factors fueling the market growth. Moreover, rising healthcare expenditure levels triggering the requirement for effective diagnostic procedures for cancer and effective government initiatives are a few factors anticipated to boost the capsule endoscopy market growth. Capsule endoscopy is recommended for patients for finding out the cause of gastrointestinal bleeding, diagnose cancer, diagnose inflammatory bowel diseases, screen for polyps and monitor celiac.

COVID-19 Impact Analysis

The COVID-19 pandemic has substantially affected the capsule endoscopy procedure. The delay, postponement, cancellation, and reduction in the number of elective surgeries performed during the COVID-19 pandemic have impacted the market significantly. In addition, changing regulations concerning surgical interventions and endoscopic screening techniques and disturbances in the supply chain are some of the major factors that have restrained the growth of the market for capsule endoscopy during the pandemic. Moreover, the advantages of capsule endoscopy boosted the market growth post-pandemic. For instance, as per the 2021 cohort study of 146 patients (74 COVID-19 positives) issued in JAMA Network, active bleeding was recognized more frequently utilizing capsule endoscopy images as the foremost strategy (around 59.5%), as compared to the traditional endoscopic detection method.

Capsule Endoscopy Market Dynamics

As machine learning advances, so does AI's potential in medicine. The use of AI in diagnostic imaging has been steadily increasing, as the technology can help clinicians and researchers save time and improve accuracy. In particular, AI-assisted capsule endoscopy which uses cameras to scan swallowed objects has recently seen a surge in adoption due to its potential to automate the process and improve accuracy. Furthermore, the emergence of technologically advanced wireless capsule endoscopy with additional features such as longer battery life, increased data storage capacity, Wi-Fi-enabled devices, intuitive designs, easy transmission, bigger frame rate, 360-degree perspective, and improved image quality are driving market growth over the capsule endoscopy market forecast period.

Market Drivers

• Various strategies by key players

There is significant competition amongst the current players due to the increasing requirement for capsule-based endoscopes and endoscopy systems for different screening and diagnostic procedures. In addition, advancements in the field of endoscopy by key players are further increasing the competition. For instance, In June 2018, Stratis Medical, Inc. was named an exclusive distributor of MicroCam Capsule Endoscopy products in the United States. Stratis Medical, Inc. has been approved and cleared to launch the first and only dual-camera capsule endoscopy system for small intestine investigation. Moreover, in August 2020, Olympus Corporation (Japan) decided to acquire Arc Medical Design Ltd. (UK). Olympus was able to increase the growth of gastrointestinal therapeutic devices, develop advanced colonoscopy tools, and enhance the early detection and treatment of colorectal cancer in the future of the acquisition.

• Increasing research and development operations

Market Restraints:

• Side effect such as capsule retention hampers the market growth

capsule retention and utilization restricted to diagnostic purposes are limitations in the capsule endoscopy market growth. The hazard of capsule retention may need endoscopic retrieval or rarely surgical resection. For instance, as per the data published in 2017 by the Annals of Translational Medicine, capsule retention happens in approximately 2% of patients undergoing a small bowel capsule endoscopy technique. This creates an obstruction in the adoption of capsule endoscopes.

• Stringent government regulations

Market Opportunities:

• Increase in the prevalence of chronic disease

The growing geriatric population base is anticipated to deliver this market with a strong platform for growth over the coming years. Aging improves the risk of gastrointestinal disorders such as inflammatory bowel disease, colorectal cancer, Crohn's disease, and appendicitis. Furthermore, the increasing prevalence of cancer in older and younger adults in recent years and the growing adoption of screening tests, including capsule endoscopy for detection, is likely to boost the market growth. As per the data provided by Cancer.Net in 2021, it is estimated that around 149,500 adults in the US will be diagnosed with colorectal cancer this year. Such growing prevalence signifies the growth of the market shortly.

• Growing investments in the development of new endoscopy capsules

Capsule Endoscopy Market Segmentation

Product Insights

The  capsule endoscopy market segmentation, based on product, is divided into capsule endoscopes, {small bowel, esophageal, and colon} and systems. The capsule endoscopes category held a prominent share in 2021 due to the growing preference of medical and healthcare professionals towards utilization of capsule endoscopy for faster and more efficient diagnosis. However,  systems is the fastest-growing category owing to the increased utilization of capsule endoscopic systems and wireless capsules.

Application Insights

The capsule endoscopy market segmentation, Based on application, is divided into OGIB (obscure GI tract bleeding), Crohn's disease, small intestine tumors, and others. The OGIB (obscure GI tract bleeding) category had a major share in 2021 due to the numerous advantages of capsule endoscopy in diagnosing and detecting OGIB. However, Crohn's disease capsule endoscopy is the fastest-growing category due to the growing usage of capsule endoscopes for the diagnosis of Crohn's disease.

End-use Insights

Based on end-use, the  capsule endoscopy market is divided into hospitals, ambulatory surgery centers, and others. The hospitals category had a major share in 2021, as hospitals are usually the primary health systems in most countries. Hence, the number of screenings conducted in hospitals is higher, thereby signifying greater adoption and demand. However, ambulatory surgery centers is the fastest-growing category as the minimal time needed for capsule endoscopy screening procedures, and faster results are the key factors supporting the demand for these procedures in ambulatory surgical centers/clinics systems.

Global Capsule Endoscopy Market Share by Region, 2021 (%)

Capsule Endoscopy Market Overview, by Region

By region, the  capsule endoscopy market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the most extensive market share. Europe is projected to exhibit the highest CAGR during the review period.

North America

North America held a major share in 2021 due to a growing preference for minimally invasive screening methods, along with the adoption of technologically advanced products and systems. In addition, Canada has one of the highest incidence rates of IBD, such as Crohn's disease and ulcerative colitis. For instance, as per the statistics provided by Crohn's and Colitis Canada in 2018, around 270,000 people in the country live with IBD, out of which 135,000 are living with Crohn's disease. It is a substantially high number. In addition, the IBD prevalence rate is anticipated to increase by 50% by 2030, with around 400,000 Canadians diagnosed with IBD.

Asia-Pacific

Asia-Pacific was the fastest-growing region in 2021. It is attributable to the higher demand for capsule-based endoscopic technologies for screening procedures in this region. In addition, the other key factors supporting growth are improving healthcare infrastructure and the rising geriatric population. The presence of major players and the constant receiving of FDA approvals are further encouraging market growth. For instance, in March 2020, enlightenVue received the US FDA 510(k) clearance for the surgiVue single-use platform of micro endoscopes.

Capsule Endoscopy Market Competitive Landscape

The market includes tier-1, tier-2, and local players. The tier-1 and tier-2 players have  reach with diverse product portfolios. Companies such as Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd, and CapsoVision., dominate the  capsule endoscopy market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are concentrating on supporting research and development. Furthermore, they embrace strategic growth initiatives, such as development, product introduction, joint ventures, and partnerships, to strengthen their market position and capture an extensive customer base. For instance, in November 2021, Medtronic announced its partnership with Amazon for home delivery of its capsule endoscope-PillCam Genius. It will help in increasing its penetration at a  level and enhancing patient comfort and satisfaction.

Prominent players in the market include RF System lab, AccuRead Endoscopy Inc., Boston Scientific Corporation, Northside Gastroenterology Endoscopy Center, LLC, Chongqing Jinshan Science & Technology Co., Interscope Inc., and Given Imaging Ltd. among others.

Scope of the  Capsule Endoscopy Market Report

Product Outlook

• Capsule Endoscopes
  
  
  
  • Small Bowel
  
  
  • Esophageal
  
  
  • Colon
  
  
  
  


• Systems

Application Outlook

• OGIB (Obscure GI Tract Bleeding)


• Crohn’s Disease


• Small Intestine Tumor


• Others

End-User Outlook

• Hospitals


• Ambulatory Surgery Centers


• Others

Region Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  • Mexico
  
  
  
  


• Europe
  
  
  
  • UK
  
  
  • Germany
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • Australia and New Zealand
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • South America
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

Capsule Endoscopy Market Forecast & Size:

To identify and estimate the market size for the  capsule endoscopy market report by product, application, and end-user, by value (in US dollars). Also, to understand the consumption/ demand created by consumers of capsule endoscopy between 2020 and 2030

Market Landscape and Trends:

To identify and infer the drivers, restraints, opportunities, and challenges for the  capsule endoscopy market research

Market Influencing Factors:

To find out the factors which are affecting the sales of capsule endoscopy among consumers

Impact of COVID-19:

To identify and understand the various factors involved in the  capsule endoscopy market size affected by the pandemic

Company Profiling:

To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

Intended Audience

• Capsule Endoscopy Manufacturers


• Hospitals


• Governments, Associations, and Industrial Bodies


• Investors and Trade Experts